1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Ependymoma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Myxopapillary Ependymomas 1.2.3 Subependymomas 1.2.4 Classic Ependymomas 1.2.5 Anaplastic Ependymomas 1.3 Market by Application 1.3.1 Global Ependymoma Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Children 1.3.3 Adults 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Ependymoma Market Perspective (2016-2027) 2.2 Ependymoma Growth Trends by Regions 2.2.1 Ependymoma Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Ependymoma Historic Market Share by Regions (2016-2021) 2.2.3 Ependymoma Forecasted Market Size by Regions (2022-2027) 2.3 Ependymoma Industry Dynamic 2.3.1 Ependymoma Market Trends 2.3.2 Ependymoma Market Drivers 2.3.3 Ependymoma Market Challenges 2.3.4 Ependymoma Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Ependymoma Players by Revenue 3.1.1 Global Top Ependymoma Players by Revenue (2016-2021) 3.1.2 Global Ependymoma Revenue Market Share by Players (2016-2021) 3.2 Global Ependymoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Ependymoma Revenue 3.4 Global Ependymoma Market Concentration Ratio 3.4.1 Global Ependymoma Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Ependymoma Revenue in 2020 3.5 Ependymoma Key Players Head office and Area Served 3.6 Key Players Ependymoma Product Solution and Service 3.7 Date of Enter into Ependymoma Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Ependymoma Breakdown Data by Type 4.1 Global Ependymoma Historic Market Size by Type (2016-2021) 4.2 Global Ependymoma Forecasted Market Size by Type (2022-2027) 5 Ependymoma Breakdown Data by Application 5.1 Global Ependymoma Historic Market Size by Application (2016-2021) 5.2 Global Ependymoma Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Ependymoma Market Size (2016-2027) 6.2 North America Ependymoma Market Size by Type 6.2.1 North America Ependymoma Market Size by Type (2016-2021) 6.2.2 North America Ependymoma Market Size by Type (2022-2027) 6.2.3 North America Ependymoma Market Size by Type (2016-2027) 6.3 North America Ependymoma Market Size by Application 6.3.1 North America Ependymoma Market Size by Application (2016-2021) 6.3.2 North America Ependymoma Market Size by Application (2022-2027) 6.3.3 North America Ependymoma Market Size by Application (2016-2027) 6.4 North America Ependymoma Market Size by Country 6.4.1 North America Ependymoma Market Size by Country (2016-2021) 6.4.2 North America Ependymoma Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Ependymoma Market Size (2016-2027) 7.2 Europe Ependymoma Market Size by Type 7.2.1 Europe Ependymoma Market Size by Type (2016-2021) 7.2.2 Europe Ependymoma Market Size by Type (2022-2027) 7.2.3 Europe Ependymoma Market Size by Type (2016-2027) 7.3 Europe Ependymoma Market Size by Application 7.3.1 Europe Ependymoma Market Size by Application (2016-2021) 7.3.2 Europe Ependymoma Market Size by Application (2022-2027) 7.3.3 Europe Ependymoma Market Size by Application (2016-2027) 7.4 Europe Ependymoma Market Size by Country 7.4.1 Europe Ependymoma Market Size by Country (2016-2021) 7.4.2 Europe Ependymoma Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Ependymoma Market Size (2016-2027) 8.2 Asia-Pacific Ependymoma Market Size by Type 8.2.1 Asia-Pacific Ependymoma Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Ependymoma Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Ependymoma Market Size by Type (2016-2027) 8.3 Asia-Pacific Ependymoma Market Size by Application 8.3.1 Asia-Pacific Ependymoma Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Ependymoma Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Ependymoma Market Size by Application (2016-2027) 8.4 Asia-Pacific Ependymoma Market Size by Region 8.4.1 Asia-Pacific Ependymoma Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Ependymoma Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Ependymoma Market Size (2016-2027) 9.2 Latin America Ependymoma Market Size by Type 9.2.1 Latin America Ependymoma Market Size by Type (2016-2021) 9.2.2 Latin America Ependymoma Market Size by Type (2022-2027) 9.2.3 Latin America Ependymoma Market Size by Type (2016-2027) 9.3 Latin America Ependymoma Market Size by Application 9.3.1 Latin America Ependymoma Market Size by Application (2016-2021) 9.3.2 Latin America Ependymoma Market Size by Application (2022-2027) 9.3.3 Latin America Ependymoma Market Size by Application (2016-2027) 9.4 Latin America Ependymoma Market Size by Country 9.4.1 Latin America Ependymoma Market Size by Country (2016-2021) 9.4.2 Latin America Ependymoma Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Ependymoma Market Size (2016-2027) 10.2 Middle East & Africa Ependymoma Market Size by Type 10.2.1 Middle East & Africa Ependymoma Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Ependymoma Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Ependymoma Market Size by Type (2016-2027) 10.3 Middle East & Africa Ependymoma Market Size by Application 10.3.1 Middle East & Africa Ependymoma Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Ependymoma Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Ependymoma Market Size by Application (2016-2027) 10.4 Middle East & Africa Ependymoma Market Size by Country 10.4.1 Middle East & Africa Ependymoma Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Ependymoma Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly 11.1.1 Eli Lilly Company Details 11.1.2 Eli Lilly Business Overview 11.1.3 Eli Lilly Ependymoma Introduction 11.1.4 Eli Lilly Revenue in Ependymoma Business (2016-2021) 11.1.5 Eli Lilly Recent Development 11.2 Astellas 11.2.1 Astellas Company Details 11.2.2 Astellas Business Overview 11.2.3 Astellas Ependymoma Introduction 11.2.4 Astellas Revenue in Ependymoma Business (2016-2021) 11.2.5 Astellas Recent Development 11.3 DNAtrix 11.3.1 DNAtrix Company Details 11.3.2 DNAtrix Business Overview 11.3.3 DNAtrix Ependymoma Introduction 11.3.4 DNAtrix Revenue in Ependymoma Business (2016-2021) 11.3.5 DNAtrix Recent Development 11.4 Advantagene 11.4.1 Advantagene Company Details 11.4.2 Advantagene Business Overview 11.4.3 Advantagene Ependymoma Introduction 11.4.4 Advantagene Revenue in Ependymoma Business (2016-2021) 11.4.5 Advantagene Recent Development 11.5 Burzynski Research Institute 11.5.1 Burzynski Research Institute Company Details 11.5.2 Burzynski Research Institute Business Overview 11.5.3 Burzynski Research Institute Ependymoma Introduction 11.5.4 Burzynski Research Institute Revenue in Ependymoma Business (2016-2021) 11.5.5 Burzynski Research Institute Recent Development 11.6 Direct Therapeutics 11.6.1 Direct Therapeutics Company Details 11.6.2 Direct Therapeutics Business Overview 11.6.3 Direct Therapeutics Ependymoma Introduction 11.6.4 Direct Therapeutics Revenue in Ependymoma Business (2016-2021) 11.6.5 Direct Therapeutics Recent Development 11.7 Cellectar Biosciences 11.7.1 Cellectar Biosciences Company Details 11.7.2 Cellectar Biosciences Business Overview 11.7.3 Cellectar Biosciences Ependymoma Introduction 11.7.4 Cellectar Biosciences Revenue in Ependymoma Business (2016-2021) 11.7.5 Cellectar Biosciences Recent Development 11.8 Amgen 11.8.1 Amgen Company Details 11.8.2 Amgen Business Overview 11.8.3 Amgen Ependymoma Introduction 11.8.4 Amgen Revenue in Ependymoma Business (2016-2021) 11.8.5 Amgen Recent Development 11.9 Boehringer Ingelheim 11.9.1 Boehringer Ingelheim Company Details 11.9.2 Boehringer Ingelheim Business Overview 11.9.3 Boehringer Ingelheim Ependymoma Introduction 11.9.4 Boehringer Ingelheim Revenue in Ependymoma Business (2016-2021) 11.9.5 Boehringer Ingelheim Recent Development 11.10 Bristol-Myers Squibb 11.10.1 Bristol-Myers Squibb Company Details 11.10.2 Bristol-Myers Squibb Business Overview 11.10.3 Bristol-Myers Squibb Ependymoma Introduction 11.10.4 Bristol-Myers Squibb Revenue in Ependymoma Business (2016-2021) 11.10.5 Bristol-Myers Squibb Recent Development 11.11 Celgene 11.11.1 Celgene Company Details 11.11.2 Celgene Business Overview 11.11.3 Celgene Ependymoma Introduction 11.11.4 Celgene Revenue in Ependymoma Business (2016-2021) 11.11.5 Celgene Recent Development 11.12 Novartis 11.12.1 Novartis Company Details 11.12.2 Novartis Business Overview 11.12.3 Novartis Ependymoma Introduction 11.12.4 Novartis Revenue in Ependymoma Business (2016-2021) 11.12.5 Novartis Recent Development 11.13 NewLink Genetics 11.13.1 NewLink Genetics Company Details 11.13.2 NewLink Genetics Business Overview 11.13.3 NewLink Genetics Ependymoma Introduction 11.13.4 NewLink Genetics Revenue in Ependymoma Business (2016-2021) 11.13.5 NewLink Genetics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Ependymoma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Myxopapillary Ependymomas Table 3. Key Players of Subependymomas Table 4. Key Players of Classic Ependymomas Table 5. Key Players of Anaplastic Ependymomas Table 6. Global Ependymoma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Ependymoma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Ependymoma Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Ependymoma Market Share by Regions (2016-2021) Table 10. Global Ependymoma Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Ependymoma Market Share by Regions (2022-2027) Table 12. Ependymoma Market Trends Table 13. Ependymoma Market Drivers Table 14. Ependymoma Market Challenges Table 15. Ependymoma Market Restraints Table 16. Global Ependymoma Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Ependymoma Market Share by Players (2016-2021) Table 18. Global Top Ependymoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ependymoma as of 2020) Table 19. Ranking of Global Top Ependymoma Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Ependymoma Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Ependymoma Product Solution and Service Table 23. Date of Enter into Ependymoma Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Ependymoma Market Size by Type (2016-2021) (US$ Million) Table 26. Global Ependymoma Revenue Market Share by Type (2016-2021) Table 27. Global Ependymoma Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Ependymoma Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Ependymoma Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Ependymoma Revenue Market Share by Application (2016-2021) Table 31. Global Ependymoma Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Ependymoma Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Ependymoma Market Size by Type (2016-2021) (US$ Million) Table 34. North America Ependymoma Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Ependymoma Market Size by Application (2016-2021) (US$ Million) Table 36. North America Ependymoma Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Ependymoma Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Ependymoma Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Ependymoma Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Ependymoma Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Ependymoma Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Ependymoma Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Ependymoma Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Ependymoma Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Ependymoma Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Ependymoma Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Ependymoma Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Ependymoma Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Ependymoma Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Ependymoma Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Ependymoma Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Ependymoma Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Ependymoma Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Ependymoma Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Ependymoma Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Ependymoma Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Ependymoma Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Ependymoma Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Ependymoma Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Ependymoma Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Ependymoma Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Ependymoma Market Size by Country (2022-2027) & (US$ Million) Table 63. Eli Lilly Company Details Table 64. Eli Lilly Business Overview Table 65. Eli Lilly Ependymoma Product Table 66. Eli Lilly Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 67. Eli Lilly Recent Development Table 68. Astellas Company Details Table 69. Astellas Business Overview Table 70. Astellas Ependymoma Product Table 71. Astellas Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 72. Astellas Recent Development Table 73. DNAtrix Company Details Table 74. DNAtrix Business Overview Table 75. DNAtrix Ependymoma Product Table 76. DNAtrix Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 77. DNAtrix Recent Development Table 78. Advantagene Company Details Table 79. Advantagene Business Overview Table 80. Advantagene Ependymoma Product Table 81. Advantagene Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 82. Advantagene Recent Development Table 83. Burzynski Research Institute Company Details Table 84. Burzynski Research Institute Business Overview Table 85. Burzynski Research Institute Ependymoma Product Table 86. Burzynski Research Institute Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 87. Burzynski Research Institute Recent Development Table 88. Direct Therapeutics Company Details Table 89. Direct Therapeutics Business Overview Table 90. Direct Therapeutics Ependymoma Product Table 91. Direct Therapeutics Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 92. Direct Therapeutics Recent Development Table 93. Cellectar Biosciences Company Details Table 94. Cellectar Biosciences Business Overview Table 95. Cellectar Biosciences Ependymoma Product Table 96. Cellectar Biosciences Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 97. Cellectar Biosciences Recent Development Table 98. Amgen Company Details Table 99. Amgen Business Overview Table 100. Amgen Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 101. Amgen Recent Development Table 102. Boehringer Ingelheim Company Details Table 103. Boehringer Ingelheim Business Overview Table 104. Boehringer Ingelheim Ependymoma Product Table 105. Boehringer Ingelheim Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 106. Boehringer Ingelheim Recent Development Table 107. Bristol-Myers Squibb Company Details Table 108. Bristol-Myers Squibb Business Overview Table 109. Bristol-Myers Squibb Ependymoma Product Table 110. Bristol-Myers Squibb Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 111. Bristol-Myers Squibb Recent Development Table 112. Celgene Company Details Table 113. Celgene Business Overview Table 114. Celgene Ependymoma Product Table 115. Celgene Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 116. Celgene Recent Development Table 117. Novartis Company Details Table 118. Novartis Business Overview Table 119. Novartis Ependymoma Product Table 120. Novartis Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 121. Novartis Recent Development Table 122. NewLink Genetics Company Details Table 123. NewLink Genetics Business Overview Table 124. NewLink Genetics Ependymoma Product Table 125. NewLink Genetics Revenue in Ependymoma Business (2016-2021) & (US$ Million) Table 126. NewLink Genetics Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Ependymoma Market Share by Type: 2020 VS 2027 Figure 2. Myxopapillary Ependymomas Features Figure 3. Subependymomas Features Figure 4. Classic Ependymomas Features Figure 5. Anaplastic Ependymomas Features Figure 6. Global Ependymoma Market Share by Application: 2020 VS 2027 Figure 7. Children Case Studies Figure 8. Adults Case Studies Figure 9. Ependymoma Report Years Considered Figure 10. Global Ependymoma Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Ependymoma Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Ependymoma Market Share by Regions: 2020 VS 2027 Figure 13. Global Ependymoma Market Share by Regions (2022-2027) Figure 14. Global Ependymoma Market Share by Players in 2020 Figure 15. Global Top Ependymoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ependymoma as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Ependymoma Revenue in 2020 Figure 17. Global Ependymoma Revenue Market Share by Type (2016-2021) Figure 18. Global Ependymoma Revenue Market Share by Type (2022-2027) Figure 19. North America Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Ependymoma Market Share by Type (2016-2027) Figure 21. North America Ependymoma Market Share by Application (2016-2027) Figure 22. North America Ependymoma Market Share by Country (2016-2027) Figure 23. United States Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Ependymoma Market Share by Type (2016-2027) Figure 27. Europe Ependymoma Market Share by Application (2016-2027) Figure 28. Europe Ependymoma Market Share by Country (2016-2027) Figure 29. Germany Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Ependymoma Market Share by Type (2016-2027) Figure 37. Asia-Pacific Ependymoma Market Share by Application (2016-2027) Figure 38. Asia-Pacific Ependymoma Market Share by Region (2016-2027) Figure 39. China Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Ependymoma Market Share by Type (2016-2027) Figure 47. Latin America Ependymoma Market Share by Application (2016-2027) Figure 48. Latin America Ependymoma Market Share by Country (2016-2027) Figure 49. Mexico Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Ependymoma Market Share by Type (2016-2027) Figure 53. Middle East & Africa Ependymoma Market Share by Application (2016-2027) Figure 54. Middle East & Africa Ependymoma Market Share by Country (2016-2027) Figure 55. Turkey Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Eli Lilly Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 59. Astellas Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 60. DNAtrix Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 61. Advantagene Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 62. Burzynski Research Institute Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 63. Direct Therapeutics Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 64. Cellectar Biosciences Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 65. Amgen Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 66. Boehringer Ingelheim Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 68. Celgene Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 69. Novartis Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 70. NewLink Genetics Revenue Growth Rate in Ependymoma Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Eli Lilly Astellas DNAtrix Advantagene Burzynski Research Institute Direct Therapeutics Cellectar Biosciences Amgen Boehringer Ingelheim Bristol-Myers Squibb Celgene Novartis NewLink Genetics